Nanoco Group Plc · LSE:NANO
Nanoco — H1 FY2025 Earnings Presentation
21 slides from Nanoco's earnings presentation, Apr 22, 2025
Slide 1: Interim results presentation
Interim results presentation For the period ended 31 January 2025 22 April 2025 Clear Strategy to Maximise Value and Return Cash
Slide 2: Disclaimer
Disclaimer The following presentation is being made only to, and is only directed at, persons to whom such presentation may lawfully be communicated (“relevant persons”). Any person who is not a relevant person should not act or rely on this presentation or any of its contents. This presentation doe
Slide 3: Contents
Contents HY25 review Nanoco markets Nanoco business model & strategy CDX Progress HY25 financials 3
Slide 4: HY25 Operational Review
NANOCO* GROUP e e HY25 OPERATIONAL REVIEW
Slide 5: Achievements in HY25
Achievements in HY25 Strong progress with Focus on commercial Further developed existing customers development device expertise Completed re- Looking to further CDX process making organisation of exploit value in IP good progress company 5
Slide 6: Nanoco Market Focus – Growth Across Multiple Segments
Nanoco Market Focus – Growth Across Multiple Segments Source: IDTechEx, Yole Development, management estimates 6
Slide 7: Nanoco Market Focus – Robust Growth Drivers
Nanoco Market Focus – Robust Growth Drivers Market Application Growth Drivers Flat Panel QD-LCD • Growing popularity of mini-LED QD-LCD configuration Display (FPD) QD-OLED • Trend towards Cd-free TV’s (led by EU; followed worldwide) Micro-LED • Emergence of high-end monitor and notebook segment QD-E
Slide 8: Recent Quantum Dot (QD) Market Announcement
Recent Quantum Dot (QD) Market Announcement QD Display Market grew 42.4% in 2024, expected 27.5% growth in 2025 8
Slide 9: Nanoco Business Model
Nanoco Business Model Flat Panel Display QD-in-Resin IP Licensing QD Sale Sale QD QD-enabled QD-enabled QD Design QD Synthesis QD Layer Formulation Device system IP Licensing QD Sale QD Ink Sale Image Sensor Pursuing Multiple Business Models Along the QD Value Chain 9
Slide 10: Nanoco Strategy Execution – Update from November 2024
Nanoco Strategy Execution – Update from November 2024 Restructuring Investing in Continue Customer is largely business building Device engagement completed development Lab capabilities Right-sized the Goal: Nanoco Ink formulation Flat Panel Display: organization commercial multiple engagements perso
Slide 11: Commercial Development Update
Commercial Development Update Flat Panel Display • Market study completed; commercial targets defined • Engagements covering both existing LCD segment and emerging technologies • Leveraging trend towards Cadmium-free products (China, Taiwan) • Continue to assess and pursue opportunities to leverage
Slide 12: Seeing Through Smoke
Seeing Through Smoke QD-SWIR Camera Utilizing Nanoco HEATWAVE® PbS QDs* iPhone (VIS) CQD (1000 - 2000 nm) *Images courtesy of Emberion 12
Slide 13: CDX Progress
CDX Progress Project on track since launch – Phase 1 completed • Thorough data gathering and Virtual Data Room (VDR) • Market studies (QD market, Image Sensor market, FPD market) • Confidential Information Memorandum (CIM) • Extensive outreach (>200 targets globally) • Detailed valuation model • Num
Slide 14: HY25 Financials
NANOCO* GROUP e e HY25 Financials 15
Slide 15: Financial Highlights HY25
Financial Highlights HY25 Performance in line with expectations Revenue down Adjusted EBITDA Completed return of 13% £33m reduced to on H1 FY24 £0.5m to shareholders Period end cash Gross cash cost base Cash cost base reduced £15.5m going forward but retained core capabilities (FY24 £20.3m) £0.5m p/
Slide 16: Income Statement
Income Statement HY 25 HY 24 Change £m £m £m Revenue 3.4 4.0 (0.6) Cost of sales (0.3) (0.4) 0.1 Gross profit 3.1 3.6 (0.5) Other operating income (grants) 0.0 0.1 (0.1) R&D investment (0.7) (0.8) 0.1 Other administrative expenses (1.9) (2.2) 0.3 Adjusted EBITDA 0.5 0.7 (0.2) Other adjusting items (
Slide 17: Movement in Cash
Movement in Cash £m 0.5 0.5 3.0 0.4 1.0 0.4 20.3 15.5 FY24 Adjusted Cash Deferred Lease liabilities Return of Other H1 FY25 EBITDA exceptionals revenue capital release • Started period with £20.3m • Adjusted EBITDA offsets cash exceptionals of £0.5m • Deferred revenue included in Adjusted EBITDA of
Slide 18: Financial Summary
Financial Summary • Full year revenue will outperform market forecasts Guidance • Gross monthly cash costs c. £0.5m per month • Future commercial wins would flow through to profit and cash • Device and analytical laboratories fully operational Investing • Business development team established • Furt
Slide 19: Summary
Summary • Market forecasts support significant growth in target industries Market Expansion • Increase in number of industries looking to utilise quantum dots • Continue to explore investment opportunities through CDX process • A revitalised team with new CEO, Chairman and Commercial lead Commercial
Slide 20: Questions
NANOCO* GROUP e° QUESTIONS 21
Slide 21: Nanoco Group
NANOCO* GROUP e e